Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – Should You Buy?

Shares of Elekta AB (OTCMKTS:EKTAY) saw unusually-high trading volume on Wednesday . Approximately 9,059 shares changed hands during trading, an increase of 246% from the previous session’s volume of 2,617 shares.The stock last traded at $5.93 and had previously closed at $5.8425.

Elekta Price Performance

The company has a current ratio of 0.95, a quick ratio of 0.73 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $2.19 billion, a P/E ratio of -592.41 and a beta of 1.08. The business’s fifty day moving average price is $6.10 and its 200-day moving average price is $5.74.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings results on Thursday, March 5th. The company reported $0.09 earnings per share for the quarter. The business had revenue of $433.29 million during the quarter. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.84%. As a group, sell-side analysts predict that Elekta AB will post 0.36 earnings per share for the current fiscal year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.